Skip to main navigation Skip to search Skip to main content

Model-based assessment of replicability for genome-wide association meta-analysis

  • GWAS and Sequencing Consortium of Alcohol and Nicotine Use (GSCAN)
  • Pennsylvania State University
  • University of Minnesota Twin Cities
  • University of Colorado Boulder
  • Massachusetts Institute of Technology
  • Broad Institute
  • 23andMe Inc.
  • University of Texas Southwestern Medical Center
  • Vrije Universiteit Amsterdam
  • Kaiser Permanente
  • Virginia Commonwealth University
  • University of Utah
  • University of Michigan, Ann Arbor
  • Norwegian University of Science and Technology
  • Queensland Institute of Medical Research
  • Fred Hutchinson Cancer Research Center
  • Harvard University
  • Erasmus University Rotterdam
  • University of Tartu
  • RIKEN
  • University of Bristol
  • National Research Council of Italy
  • University of Helsinki
  • deCODE Genetics
  • University of Colorado Anschutz Medical Campus
  • The University of Osaka
  • Avera Health
  • Brown University
  • University of Iceland
  • University of North Carolina at Chapel Hill
  • Washington University St. Louis
  • The University of Sydney
  • University of Oxford
  • RTI International
  • University of Eastern Finland
  • University of Washington
  • VU University Medical Center
  • Indiana University Bloomington
  • Vogur Hospital
  • Vanderbilt University
  • University of California at San Diego
  • University of Oslo
  • Nord-Trøndelag Health Trust
  • Northwestern University
  • Stanford University

Research output: Contribution to journalArticlepeer-review

Abstract

Genome-wide association meta-analysis (GWAMA) is an effective approach to enlarge sample sizes and empower the discovery of novel associations between genotype and phenotype. Independent replication has been used as a gold-standard for validating genetic associations. However, as current GWAMA often seeks to aggregate all available datasets, it becomes impossible to find a large enough independent dataset to replicate new discoveries. Here we introduce a method, MAMBA (Meta-Analysis Model-based Assessment of replicability), for assessing the “posterior-probability-of-replicability” for identified associations by leveraging the strength and consistency of association signals between contributing studies. We demonstrate using simulations that MAMBA is more powerful and robust than existing methods, and produces more accurate genetic effects estimates. We apply MAMBA to a large-scale meta-analysis of addiction phenotypes with 1.2 million individuals. In addition to accurately identifying replicable common variant associations, MAMBA also pinpoints novel replicable rare variant associations from imputation-based GWAMA and hence greatly expands the set of analyzable variants.

Original languageEnglish
Article number1964
JournalNature Communications
Volume12
Issue number1
DOIs
Publication statusPublished - 30 Mar 2021
Externally publishedYes

Fingerprint

Dive into the research topics of 'Model-based assessment of replicability for genome-wide association meta-analysis'. Together they form a unique fingerprint.

Cite this